• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子电负性边缘距离向量(VMED)的定量序列-活性模型(QSAM)对抗具有生物活性的抗原多肽组序列进行结构参数化和功能预测。

Structural parameterization and functional prediction of antigenic polypeptome sequences with biological activity through quantitative sequence-activity models (QSAM) by molecular electronegativity edge-distance vector (VMED).

作者信息

Li ZhiLiang, Wu ShiRong, Chen ZeCong, Ye Nancy, Yang ShengXi, Liao ChunYang, Zhang MengJun, Yang Li, Mei Hu, Yang Yan, Zhao Na, Zhou Yuan, Zhou Ping, Xiong Qing, Xu Hong, Liu ShuShen, Ling ZiHua, Chen Gang, Li GenRong

机构信息

College of Chemistry and Chemical Engineering/Key Laboratory for Chemobiomedical Science and Engineering under Chongqing Municipality, Chongqing University, Chongqing 400044, China.

出版信息

Sci China C Life Sci. 2007 Oct;50(5):706-16. doi: 10.1007/s11427-007-0080-7.

DOI:10.1007/s11427-007-0080-7
PMID:17879071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7089106/
Abstract

Only from the primary structures of peptides, a new set of descriptors called the molecular electronegativity edge-distance vector (VMED) was proposed and applied to describing and characterizing the molecular structures of oligopeptides and polypeptides, based on the electronegativity of each atom or electronic charge index (ECI) of atomic clusters and the bonding distance between atom-pairs. Here, the molecular structures of antigenic polypeptides were well expressed in order to propose the automated technique for the computerized identification of helper T lymphocyte (Th) epitopes. Furthermore, a modified MED vector was proposed from the primary structures of polypeptides, based on the ECI and the relative bonding distance of the fundamental skeleton groups. The side-chains of each amino acid were here treated as a pseudo-atom. The developed VMED was easy to calculate and able to work. Some quantitative model was established for 28 immunogenic or antigenic polypeptides (AGPP) with 14 (1-14) A(d) and 14 other restricted activities assigned as "1"(+) and "0"(-), respectively. The latter comprised 6 A(b)(15-20), 3 A(k)(21-23), 2 E(k)(24-26), 2 H-2(k)(27 and 28) restricted sequences. Good results were obtained with 90% correct classification (only 2 wrong ones for 20 training samples) and 100% correct prediction (none wrong for 8 testing samples); while contrastively 100% correct classification (none wrong for 20 training samples) and 88% correct classification (1 wrong for 8 testing samples). Both stochastic samplings and cross validations were performed to demonstrate good performance. The described method may also be suitable for estimation and prediction of classes I and II for major histocompatibility antigen (MHC) epitope of human. It will be useful in immune identification and recognition of proteins and genes and in the design and development of subunit vaccines. Several quantitative structure activity relationship (QSAR) models were developed for various oligopeptides and polypeptides including 58 dipeptides and 31 pentapeptides with angiotensin converting enzyme (ACE) inhibition by multiple linear regression (MLR) method. In order to explain the ability to characterize molecular structure of polypeptides, a molecular modeling investigation on QSAR was performed for functional prediction of polypeptide sequences with antigenic activity and heptapeptide sequences with tachykinin activity through quantitative sequence-activity models (QSAMs) by the molecular electronegativity edge-distance vector (VMED). The results showed that VMED exhibited both excellent structural selectivity and good activity prediction. Moreover, the results showed that VMED behaved quite well for both QSAR and QSAM of poly-and oligopeptides, which exhibited both good estimation ability and prediction power, equal to or better than those reported in the previous references. Finally, a preliminary conclusion was drawn: both classical and modified MED vectors were very useful structural descriptors. Some suggestions were proposed for further studies on QSAR/QSAM of proteins in various fields.

摘要

仅从肽的一级结构出发,基于每个原子的电负性或原子簇的电子电荷指数(ECI)以及原子对之间的键距,提出了一种名为分子电负性边缘距离向量(VMED)的新描述符,并将其应用于描述和表征寡肽和多肽的分子结构。在此,为了提出用于辅助性T淋巴细胞(Th)表位计算机识别的自动化技术,对抗抗原多肽的分子结构进行了很好的表达。此外,基于ECI和基本骨架基团的相对键距,从多肽的一级结构中提出了一种改进的MED向量。每个氨基酸的侧链在此被视为一个伪原子。所开发的VMED易于计算且能够发挥作用。针对28种免疫原性或抗原性多肽(AGPP)建立了一些定量模型,其中14种(1 - 14)具有A(d)活性,另外14种的活性分别被指定为“1”(+)和“0”(-)。后者包括6种A(b)(15 - 20)、3种A(k)(21 - 23)、2种E(k)(24 - 26)、2种H - 2(k)(27和28)受限序列。在20个训练样本中仅2个错误,正确分类率为90%;在8个测试样本中无一错误,正确预测率为100%;相比之下,正确分类率为100%(20个训练样本无一错误),正确分类率为88%(8个测试样本中有1个错误)。进行了随机抽样和交叉验证以证明良好的性能。所描述的方法也可能适用于估计和预测人类主要组织相容性抗原(MHC)表位的I类和II类。它将有助于蛋白质和基因的免疫识别,以及亚单位疫苗的设计和开发。通过多元线性回归(MLR)方法,针对包括58种二肽和31种五肽在内的各种寡肽和多肽建立了几个定量构效关系(QSAR)模型,这些肽具有血管紧张素转换酶(ACE)抑制活性。为了解释多肽表征分子结构的能力,通过分子电负性边缘距离向量(VMED),通过定量序列 - 活性模型(QSAMs)对具有抗原活性的多肽序列和具有速激肽活性的七肽序列进行了QSAR的分子建模研究,以进行功能预测。结果表明,VMED既表现出优异的结构选择性,又具有良好的活性预测能力。此外,结果表明,VMED在多肽和寡肽的QSAR和QSAM方面表现都相当好,具有良好的估计能力和预测能力,等于或优于先前参考文献中报道的结果。最后得出一个初步结论:经典和改进的MED向量都是非常有用的结构描述符。针对不同领域中蛋白质的QSAR/QSAM进一步研究提出了一些建议。

相似文献

1
Structural parameterization and functional prediction of antigenic polypeptome sequences with biological activity through quantitative sequence-activity models (QSAM) by molecular electronegativity edge-distance vector (VMED).通过分子电负性边缘距离向量(VMED)的定量序列-活性模型(QSAM)对抗具有生物活性的抗原多肽组序列进行结构参数化和功能预测。
Sci China C Life Sci. 2007 Oct;50(5):706-16. doi: 10.1007/s11427-007-0080-7.
2
Quantitative sequence-activity model analysis of oligopeptides coupling an improved high-dimension feature selection method with support vector regression.结合改进的高维特征选择方法与支持向量回归的寡肽定量序列-活性模型分析
Chem Biol Drug Des. 2014 Apr;83(4):379-91. doi: 10.1111/cbdd.12242. Epub 2014 Feb 18.
3
Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.迈向I类和II类小鼠主要组织相容性复合体-肽结合亲和力的预测:使用定量构效关系的计算机生物信息学逐步指南
Methods Mol Biol. 2007;409:227-45. doi: 10.1007/978-1-60327-118-9_16.
4
QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors.基于一组新的序列信息描述符的血管紧张素转化酶抑制剂寡肽的定量构效关系研究。
J Mol Model. 2011 Jul;17(7):1599-606. doi: 10.1007/s00894-010-0862-x. Epub 2010 Oct 13.
5
Gaussian process: an alternative approach for QSAM modeling of peptides.高斯过程:肽 QSAM 建模的另一种方法。
Amino Acids. 2010 Jan;38(1):199-212. doi: 10.1007/s00726-008-0228-1. Epub 2009 Jan 4.
6
In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.肽与人类MHC分子结合亲和力的计算机定量预测:一种直观的定量构效关系方法。
Amino Acids. 2009 Mar;36(3):535-54. doi: 10.1007/s00726-008-0116-8. Epub 2008 Jun 25.
7
QSAR study on MHC class I a alleles based on the novel parameters of amino acids.基于氨基酸新参数的MHC I类a等位基因的定量构效关系研究
Protein Pept Lett. 2011 Sep;18(9):956-63. doi: 10.2174/092986611796011437.
8
Quantitative prediction of class I MHC/epitope binding affinity using QSAR modeling derived from amino acid structural information.利用源自氨基酸结构信息的定量构效关系模型对I类主要组织相容性复合体/表位结合亲和力进行定量预测。
Comb Chem High Throughput Screen. 2015;18(1):75-82. doi: 10.2174/1386207318666150121125746.
9
[New 3D amino acid structure descriptors and its application to the polypeptide QSAR].[新型3D氨基酸结构描述符及其在多肽定量构效关系中的应用]
Yao Xue Xue Bao. 2005 Apr;40(4):340-6.
10
Ab-initio conformational epitope structure prediction using genetic algorithm and SVM for vaccine design.基于遗传算法和 SVM 的从头构象表位结构预测在疫苗设计中的应用。
Comput Methods Programs Biomed. 2018 Jan;153:161-170. doi: 10.1016/j.cmpb.2017.10.011. Epub 2017 Oct 12.

引用本文的文献

1
Machine Learning Methods for Predicting HLA-Peptide Binding Activity.用于预测HLA-肽结合活性的机器学习方法
Bioinform Biol Insights. 2015 Oct 11;9(Suppl 3):21-9. doi: 10.4137/BBI.S29466. eCollection 2015.
2
Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function.使用改良的半经验评分函数预测肽与 MHC 分子的结合亲和力。
PLoS One. 2011;6(9):e25055. doi: 10.1371/journal.pone.0025055. Epub 2011 Sep 22.

本文引用的文献

1
Identification of encoding proteins related to SARS-CoV.与严重急性呼吸综合征冠状病毒相关的编码蛋白的鉴定
Chin Sci Bull. 2004;49(19):2037-2040. doi: 10.1360/03wb0198.
2
Scores of generalized base properties for quantitative sequence-activity modelings for E. coli promoters based on support vector machine.
J Mol Graph Model. 2007 Jul;26(1):269-81. doi: 10.1016/j.jmgm.2006.12.004. Epub 2006 Dec 15.
3
A new sequence representation as applied in better specificity elucidation for human immunodeficiency virus type 1 protease.一种用于更清晰阐释1型人类免疫缺陷病毒蛋白酶特异性的新序列表示法。
Biopolymers. 2007;88(3):401-12. doi: 10.1002/bip.20669.
4
A new set of amino acid descriptors and its application in peptide QSARs.一组新的氨基酸描述符及其在肽定量构效关系中的应用。
Biopolymers. 2005;80(6):775-86. doi: 10.1002/bip.20296.
5
Identification of binding epitope of a monoclonal antibody (Z12) against human TNF-alpha using computer modeling and deletion mutant technique.
Sci China C Life Sci. 2004 Jun;47(3):279-86. doi: 10.1007/BF03182773.
6
The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain.还原多肽链氧化过程中天然核糖核酸酶的形成动力学。
Proc Natl Acad Sci U S A. 1961 Sep 15;47(9):1309-14. doi: 10.1073/pnas.47.9.1309.
7
The mechanism of p21-activated kinase 2 autoactivation.p21激活激酶2的自激活机制。
J Biol Chem. 2003 Oct 24;278(43):41768-78. doi: 10.1074/jbc.M308196200. Epub 2003 Aug 7.
8
Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.p21激活蛋白激酶PAK2催化机制的评估
Biochemistry. 2003 Feb 4;42(4):1129-39. doi: 10.1021/bi026857l.
9
Autophosphorylation kinetics of protein kinases.蛋白激酶的自磷酸化动力学
Biochem J. 2002 Dec 15;368(Pt 3):947-52. doi: 10.1042/BJ20020557.
10
QSAR study of steroid benchmark and dipeptides based on MEDV-13.基于MEDV-13的甾体基准和二肽的定量构效关系研究
J Chem Inf Comput Sci. 2001 Mar-Apr;41(2):321-9. doi: 10.1021/ci0003350.